Company news
Cumberland Pharmaceuticals Inc. news in 2020
Cumberland Pharmaceuticals Inc.'s news releases, calls and decks from 2020, newest first.
Introducing RediTrex®, A New Methotrexate Delivery System
November 16, 2020
Cumberland Pharmaceuticals Reports Third Quarter 2020 Financial Results & Company Update
November 9, 2020
Cumberland Pharmaceuticals To Announce Third Quarter 2020 Financial Results
November 2, 2020
Cumberland Pharmaceuticals Reports Second Quarter 2020 Financial Results & Company Update
August 10, 2020
Caldolor® Demonstrates Significant Reduction Of Opioid Use In Orthopedic Trauma Patients
July 19, 2020
Cumberland Pharmaceuticals Reports First Quarter 2020 Financial Results & Company Update
May 19, 2020
Cumberland Pharmaceuticals Releases Inaugural Report On Its Environmental, Social And Governance (ESG) Activities
April 27, 2020
To Help Prepare for the COVID-19 Patient Surge Cumberland Pharmaceuticals Expands Availability of Vaprisol® to Treat Hyponatremia in Critical Care Units
April 6, 2020
Cumberland Pharmaceuticals Announces Initiative to Expand Availability of Caldolor® to Help Treat High Fevers Associated With Coronavirus Infections
March 30, 2020
Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
March 22, 2020
Cumberland Pharmaceuticals Reports 17% Revenue Growth For The Full Year 2019
March 17, 2020
Cumberland Pharmaceuticals Reschedules Fourth Quarter And Annual 2019 Financial Results
March 5, 2020
Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product
January 6, 2020